BYUNGKYU OH,CHANGHEE MIN,CHANGMIN PARK,YONGEUN KIM
申请号：
BR112017016465
公开号：
BR112017016465A2
申请日:
2016.02.02
申请国别(地区):
BR
年份:
2018
代理人:
摘要：
The invention relates to a novel heterocyclic compound inhibiting a cyclin-dependent kinase (CDK) and a pharmaceutical composition comprising the same as an effective ingredient. The heterocyclic compound according to the present invention or pharmaceutically acceptable salt thereof can be effectively used in treating or preventing cancers, degenerative brain diseases, etc.
